Sponsor Pipeline

MEI HENG Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07233018 A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/ Refractory… Relapsed/Refractory Acute Myeloid Leukemia(AML) Not Yet Recruiting
Disease Areas
Leukemia (1) Acute Myeloid Leukemia (AML) (1)
Get alerts when MEI HENG's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free